China's ByteDance Spins Off AI Drug Discovery Unit, Seeks Independent Funding
ByteDance's artificial intelligence drug discovery unit has initiated a spin-off and is seeking inde...
Bayer Becomes Founding Member of International Society for Stem Cell Research Consortium
The International Society for Stem Cell Research (ISSCR) announced that Bayer has become a founding ...
EU Proposes Biotech Act to Balance Patent Protection and Generic Competition
The European Union plans to introduce the Biotech Act to enhance the global competitiveness of Europ...
Harbour BioMed and BioMap to Jointly Establish AI Pipeline R&D Company
On June 15, Harbour BioMed and BioMap jointly announced a multi-level, long-term comprehensive strat...
Guangzhou Atom High-Tech and Guangdong Radiation Protection Association Advance Fluorine-18 Drug Standards
Guangzhou Atom High-Tech Isotope Pharmaceutical Co., Ltd. recently exchanged views with the Guangdon...
U.S. FDA Approves KEYTRUDA in Combination with WELIREG for Adjuvant Treatment of Renal Cell Carcinoma
The U.S. FDA has approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab with berahyaluro...
South Korea's Rznomics Announces Interim Clinical Data for RZ-001 in Treating rGBM
Rznomics' RNA editing-based anticancer gene therapy, RZ-001 (Taspitimagene advec), has demonstrated ...
Ascendis Reports 182-Week Data for YORVIPATH in Hypoparathyroidism
Danish biopharmaceutical company Ascendis Pharma A/S (Nasdaq: ASND) announced 182-week data from the...
Colombia Passes Bill to Authorize Local Production of Cancer Treatment Radiopharmaceuticals
Colombia's Congress has passed a new bill authorizing the domestic production of radiopharmaceutical...
Netherlands completes world's first in vivo CRISPR Phase III trial, reducing attacks by 87%
The research team has successfully completed the world's first Phase III trial of an in vivo CRISPR ...